BCAR3

GI:4502371

breast cancer antiestrogen resistance 3

     1  maagkfaslp rnmpvnhqfp lassmdllss rsplaehrpd ayqdvsihgt  50    
    51  lprkkkgppp irscddfshm gtlphskspr qnspvtqdgi qespwqdrhg  100   
   101  etftfrdphl ldptveyvkf skerhimdrt peklkkelee elllssedlr  150   
   151  shawyhgrip rqvsenlvqr dgdflvrdsl sspgnfvltc qwknlaqhfk  200   
   201  inrtvlrlse aysrvqyqfe mesfdsipgl vrcyvgnrrp isqqsgaiif  250   
   251  qpinrtvplr cleehygtsp gqaregsltk grpdvakrls ltmggvqare  300   
   301  qnlprgnllr nkeksgsqpa cldhmqdrra lslkahqses ylpigcklpp  350   
   351  qssgvdtspc pnspvfrtgs epalspavvr rvssdarage alrgsdsqlc  400   
   401  pkpppkpckv pflkvpssps awlnseanyc elnpafatgc grgaklpsca  450   
   451  qgshtellta kqneapgprn sgvnylildd ddrerpwepa aaqmekgqwd  500   
   501  kgefvtplle tvssfrpnef eskflppenk pletamlkra kelftnndpk  550   
   551  viaqhvlsmd crvarilgvs eemrrnmgvs sglelitlph ghqlrldiie  600   
   601  rhntmaigia vdilgctgtl edraatlski iqvavelkds mgdlysfsal  650   
   651  mkalempqit rlektwtalr hqytqtaily ekqlkpfskl lhegrestcv  700   
   701  ppnnvsvpll mplvtlmerq avtfegtdmw ekndqsceim lnhlatarfm  750   
   751  aeaadsyrmn aerilagfqp deemneickt efqmrllwgs kgaqvnqter  800   
   801  yekfnqilta lsrklepppv kqael